Assessment of African swine fever vaccine candidate ASFV-G-∆MGF in a reversion to virulence study

Assessment of African swine fever vaccine candidate ASFV-G-∆MGF in a reversion to virulence study

Abstract African swine fever (ASF) has gained panzootic dimensions and commercial vaccines are still unavailable. Recently, a series of live attenuated vaccines has raised hope for an efficacious and safe vaccine, among them “ASFV-G-∆MGF”. We tested the latter in an in vivo reversion to virulence st...

Full description

Bibliographic Details
Main Authors: Paul Deutschmann, Jan-Hendrik Forth, Julia Sehl-Ewert, Tessa Carrau, Elisenda Viaplana, Jose Carlos Mancera, Alicia Urniza, Martin Beer, Sandra Blome
Format: Article
Language:English
Published: Nature Portfolio 2023-05-01
Series:npj Vaccines
Online Access:https://doi.org/10.1038/s41541-023-00669-z

Internet

https://doi.org/10.1038/s41541-023-00669-z

Similar Items